Answers are grounded in this paper and cite their sources.
The study aims to improve glioblastoma multiforme (GBM) treatment by combining temozolomide (TMZ) and quercetin (Qct), using folic acid (FA)-conjugated exosomes to overcome TMZ resistance and enhance blood-brain barrier (BBB) penetration.
No takes yet. Share an insight, caveat, or question.
Pourmasoumi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: